Insomnia found to be common among nonhospitalized COVID-19 survivors
Feb 13, 2024
The risk for insomnia was even higher for those with depression or anxiety.
COVID-19 tied to significant increase in outpatient healthcare
Feb 13, 2024
The greatest increase in utilization was seen for veterans aged 85 years and older (6.1 visits) versus those aged 20 to 44 years (4.8 visits).
COVID-19 mRNA vaccines safe during pregnancy
Feb 13, 2024
In a large study, there were lower odds of neonatal mortality associated with vaccination.
Proposed legislation would dedicate $5 million for telemedicine infrastructure for assisted living, nursing...
By
Kimberly Bonvissuto
Feb 13, 2024
Expanding access to telehealth is the goal of a proposed bill in South Dakota that would provide millions in funding for assisted living communities and nursing homes across the state to implement telemedicine...
South Dakota campaign joins state and federal efforts to expand rural telehealth access
By
Aaron Dorman
Feb 12, 2024
South Dakota is working on legislation to grant $5 million to long-term care facilities in the state to implement telehealth and telemedicine access.
Online physical, mental rehab aids quality of life with long COVID
Feb 09, 2024
The findings were clinically significant at three and 12 months versus usual care.
Dr. Anthony Fauci to publish memoir ‘On Call’ in June
Feb 08, 2024
His publisher, Viking, announced that the book will go on sale June 18.
Updated COVID-19 vaccine has effectiveness of 54 percent
Feb 06, 2024
Vaccine effectiveness was 49% at 60 to 119 days after vaccination among tests exhibiting spike gene target failure.
Business briefs, Feb. 6
By
Kathleen Steele Gaivin
Feb 06, 2024
Arbitration not valid in COVID wrongful death cases: court … Petersen Health Care in battle for share of massive nursing home portfolio … Federal, state assisted living quality measures fail to inform...
Prolonged SARS-CoV-2 risk varies across immunosuppressive conditions
Jan 31, 2024
Severely immunocompromised individuals had greater SARS-CoV-2 evolution and a higher risk for developing resistance against therapeutic mAbs.